U.S. Markets open in 4 hrs 40 mins

CEL-SCI Corporation (CVM)

NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.25-0.12 (-5.06%)
At close: 3:57PM EDT
People also watch
HEBCYTRCTICAGENGNBT
Full screen
Previous Close2.37
Open2.33
Bid0.00 x
Ask3.41 x 900
Day's Range2.21 - 2.29
52 Week Range0.06 - 2.95
Volume45,724
Avg. Volume3,063,368
Market Cap20.74M
Beta-0.51
PE Ratio (TTM)-1.35
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1996-08-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • CEL-SCI Corp. :CVM-US: Earnings Analysis: Q2, 2017 By the Numbers : June 19, 2017
    Capital Cubelast month

    CEL-SCI Corp. :CVM-US: Earnings Analysis: Q2, 2017 By the Numbers : June 19, 2017

    Categories: Yahoo FinanceGet free summary analysis CEL-SCI Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CEL-SCI Corp. – Curis, Inc., BioCryst Pharmaceuticals, Inc., Amgen Inc., Xencor, Inc., CytRx Corporation, Johnson & Johnson, Vical Incorporated, Teva Pharmaceutical Industries Limited Sponsored ADR and Emergent BioSolutions Inc. ... Read more (Read more...)

  • Associated Press3 months ago

    Cel-Sci reports 2Q loss

    On a per-share basis, the Vienna, Virginia-based company said it had a loss of 5 cents. The cancer immunotherapy company posted revenue of $17,200 in the period. Its adjusted revenue was $17,000. In the ...

  • TheStreet.com3 months ago

    A Neurotrope Stock Promotion Scheme Is Underway, but Who's Paying for It?

    Sharon di Stefano loves Neurotrope but doesn't know how her Seeking Alpha articles are being transformed into stock-promoting press releases.